Published in Hepatitis Weekly, June 14th, 2004
In this model, presented as a liver disease poster-of-distinction at the annual Digestive Disease Week meeting in New Orleans, Louisiana, the addition of histamine reduced pro-inflammatory cytokines and substantially increased survival in LPS-induced liver injury after partial liver resection (hepatectomy).
Maxim scientists recently presented data at the 54th American Association for the Study of Liver Diseases last October showing the ability of histamine to accelerate liver...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-06-14)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.